Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$892M |
| 2 |
Merck
MRK
|
+$858M |
| 3 |
Amgen
AMGN
|
+$857M |
| 4 |
Home Depot
HD
|
+$837M |
| 5 |
Cisco
CSCO
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$776M |
| 2 |
United Parcel Service
UPS
|
+$615M |
| 3 |
Qualcomm
QCOM
|
+$587M |
| 4 |
Alibaba
BABA
|
+$555M |
| 5 |
Eaton
ETN
|
+$508M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Financials | 12.96% |
| 3 | Healthcare | 11.88% |
| 4 | Consumer Discretionary | 11.22% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EAR
2501
DELISTED
Eargo, Inc. Common Stock
EAR
| $3.25M | ﹤0.01% |
3,252
+84
| +3% | +$95.9K |
|
2502
Prelude Therapeutics
PRLD
$350M
| $3.24M | ﹤0.01% |
74,668
+6,100
| +9% | +$405K |
|
2503
Metallus
MTUS
$851M
| $3.23M | ﹤0.01% |
274,975
-713,575
| -72% | -$5.33M |
|
|
DSKE
2504
DELISTED
Daseke, Inc. Common Stock
DSKE
| $3.23M | ﹤0.01% |
380,292
-38,895
| -9% | -$238K |
|
|
AKRO
2505
DELISTED
Akero Therapeutics
AKRO
| $3.22M | ﹤0.01% |
111,111
+3,179
| +3% | +$96.2K |
|
|
SPPI
2506
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $3.22M | ﹤0.01% |
988,371
+18,249
| +2% | +$65.4K |
|
2507
Stratasys
SSYS
$706M
| $3.22M | ﹤0.01% |
124,156
-12,533
| -9% | -$432K |
|
|
EGRX
2508
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.21M | ﹤0.01% |
77,003
+1,809
| +2% | +$84K |
|
2509
Forrester Research
FORR
$221M
| $3.21M | ﹤0.01% |
75,502
+3,614
| +5% | +$157K |
|
|
ITOS
2510
DELISTED
iTeos Therapeutics
ITOS
| $3.2M | ﹤0.01% |
93,712
+18,961
| +25% | +$685K |
|
2511
TherapeuticsMD
TXMD
$23.6M
| $3.2M | ﹤0.01% |
47,790
+12,432
| +35% | +$973K |
|
|
PLYA
2512
DELISTED
Playa Hotels & Resorts
PLYA
| $3.2M | ﹤0.01% |
438,443
+188,128
| +75% | +$1.24M |
|
|
TRUE
2513
DELISTED
TrueCar
TRUE
| $3.2M | ﹤0.01% |
668,849
+16,009
| +2% | +$79.3K |
|
2514
Expro Ltd
XPRO
$1.79B
| $3.19M | ﹤0.01% |
149,938
-151,318
| -50% | -$3.29M |
|
|
TELL
2515
DELISTED
Tellurian Inc.
TELL
| $3.18M | ﹤0.01% |
1,360,168
+165,921
| +14% | +$453K |
|
|
DHIL
2516
DELISTED
Diamond Hill
DHIL
| $3.18M | ﹤0.01% |
20,361
+1,289
| +7% | +$198K |
|
2517
Scholar Rock
SRRK
$5.49B
| $3.16M | ﹤0.01% |
62,334
+1,223
| +2% | +$67.7K |
|
2518
Vor Biopharma
VOR
$1.16B
| $3.16M | ﹤0.01% |
+3,662
| New | +$3.1M |
|
|
LOGC
2519
DELISTED
ContextLogic
LOGC
| $3.15M | ﹤0.01% |
+6,646
| New | +$4.4M |
|
|
CIO
2520
DELISTED
City Office REIT
CIO
| $3.15M | ﹤0.01% |
296,264
+7,986
| +3% | +$81.6K |
|
|
RNAM
2521
DELISTED
Avidity Biosciences
RNAM
| $3.13M | ﹤0.01% |
143,705
+33,902
| +31% | +$830K |
|
|
GDEN
2522
DELISTED
Golden Entertainment
GDEN
| $3.13M | ﹤0.01% |
123,956
+3,111
| +3% | +$69.9K |
|
2523
Omega Flex
OFLX
$305M
| $3.13M | ﹤0.01% |
19,823
+30
| +0.2% | +$4.72K |
|
2524
Bristow Group
VTOL
$1.35B
| $3.12M | ﹤0.01% |
120,614
+792
| +0.7% | +$21.6K |
|
|
GLOG
2525
DELISTED
GASLOG LTD
GLOG
| $3.11M | ﹤0.01% |
539,512
+11,370
| +2% | +$59.1K |
|
Similar funds
Charles Schwab's Q1 2021 Portfolio in Review
As of Q1 2021, Charles Schwab held 3,565 positions worth $273B, up 8.3% from $252B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Charles Schwab's Q1 2021 filing shows 168 new, 2,233 increased, 898 reduced and 80 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M. The largest sale was ExxonMobil, an estimated $776M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2021 buy was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M.
- Charles Schwab added most to Broadcom in Q1 2021, an estimated $892M increase.
- Charles Schwab's biggest Q1 2021 reduction was ExxonMobil, cutting an estimated $776M.
- Charles Schwab fully exited Invesco QQQ Trust in Q1 2021, selling an estimated $396M.
- Charles Schwab's ten largest holdings make up 16% of its $273B portfolio in Q1 2021.
- Charles Schwab opened 168 new positions and closed 80 in Q1 2021.
- Charles Schwab's portfolio value rose 8.3% quarter-over-quarter to $273B.
Based on Charles Schwab's 13F filing for Q1 2021, filed 17 May 2021.